Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > DEA TOX

DEA TOX TOXICOLOGY TESTING PROGRAM

DEA TOX Logo

Contact: DEATOX@USDOJ.GOV

In response to the ongoing novel synthetic drug abuse epidemic, the Drug Enforcement Administration (DEA) has initiated a contract with the University of California at San Francisco (UCSF) whereby biological samples generated from drug overdose victims can be further analyzed for identification of these synthetic drugs. In many drug overdose cases, it can be difficult to identify novel synthetic drugs because routine forensic drug screens do not typically target such substances. We invite medical and law enforcement facilities to contact our program if you encounter an overdose of a suspected synthetic drug and desire to have any leftover biological samples (blood preferred) analyzed further for such synthetic substances.

Sample Qualifications and Requesting Testing

Collecting, Labeling, and Shipment of Samples (PDF)

Cost and Time of Sample Analysis

The DEA will cover the full cost of testing the patient samples received at UCSF. The originating medical facility will only be responsible for paying for packing and shipping samples to UCSF.

Results are expected to be returned to the originating requestor within three weeks of receipt of the sample at UCSF except in rare occurrences when a novel substance is identified.

UCSF Laboratory Information

Quarterly Reports

Quarterly reports are designed to demonstrate the locations and substances identified during these time points. Results are organized based upon the time-frame the sample was received and analyzed at UCSF.

1st Quarter 2021 DEA TOX (PDF)

4th Quarter 2020 DEA TOX (PDF)

Announcements

Alert Regarding 2-Methyl AP-237 (June 11, 2021)

Alert Regarding N-Methyl-2-Aminoindane (NM-2-AI) (PDF) (May 13, 2021)

Newly Identified Cathinone alpha-Piperidinobutiophenone (α-PipBP) (PDF) (March 23, 2021)

Newly Identified Synthetic Cannabinoid 4CN-AB-BUTICA (PDF) (February 25, 2021)

Newly Identified Synthetic Cannabinoid ADB-P7AICA (PDF) (February 25, 2021)

Newly Identified Synthetic Cannabinoid 4-CN-AMB-BUTINACA (PDF) (December 17, 2020)

Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility